Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03269149 · ClinicalTrials.gov registry record · NA

Tango for Alzheimer's Disease Patients' Caregivers

A NA study of Alzheimers Disease, sponsored by Emory University.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT03269149 is a NA study of Alzheimers Disease that is active but no longer recruiting, run by Emory University. The registered enrollment target is 60 participants, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03269149, a NA study of Alzheimers Disease, is active but no longer recruiting, sponsored by Emory University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of the project is to determine the extent to which indices of inflammatory biomarkers, cognition and mood, are influenced by a partnered, dance-based intervention vs control condition in African American (AA) female family caregivers, at high risk for Alzheimer's disease (AD).

Conditions Studied

Interventions

  • OTHER Adapted Tango Dance
  • BEHAVIORAL Educational lectures

Study Locations (1)

Georgia

  • Atlanta VA Medical Center, Emory University, Executive Park, Wesley Woods - Atlanta

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-09-19
Est. Completion 2026-04
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT03269149

The ClinicalTrials.gov registry entry for NCT03269149 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (99% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 2 interventions - of which Adapted Tango Dance is the first listed.

NCT03269149 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT03269149 about?

NCT03269149 is a clinical study titled "Tango for Alzheimer's Disease Patients' Caregivers". The goal of the project is to determine the extent to which indices of inflammatory biomarkers, cognition and mood, are influenced by a partnered, dance-based intervention vs control condition in African American (AA) female family caregivers, at high risk for Alzheimer's disease (AD).

What is the current status of trial NCT03269149?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2017-09-19. Estimated completion is 2026-04.

What conditions does trial NCT03269149 study?

This clinical trial studies the following conditions: Alzheimers Disease.

What interventions are being tested in trial NCT03269149?

The interventions under investigation include: Adapted Tango Dance (OTHER), Educational lectures (BEHAVIORAL).

Who is sponsoring clinical trial NCT03269149?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03269149 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimers Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.